Reduced serum progranulin level might be associated with Parkinson's disease risk
- 9 February 2013
- journal article
- research article
- Published by Wiley in European Journal of Neurology
- Vol. 20 (12) , 1571-1573
Abstract
Background and purpose: Common genetic variants (rs5848 and rs646776) have been reported as regulators of blood progranulin (GRN) levels in healthy individuals.Methods: To assess the influence of rs5848 and rs646776 polymorphisms in both serum GRN level and risk for common neurodegenerative diseases, we studied 304 patients with Parkinson's disease (PD), 217 individuals with Alzheimer's disease, 131 subjects with mild cognitive impairment, and 126 controls.Results: The mean concentration of GRN in the serum of patients with PD (319.6 ng/ml) was significantly lower than that of controls (371.5 ng/ml; P = 0.009), whereas there were no significant differences between other groups. Rs646776 minor allele carriers had lower serum GRN levels in each of the four subgroups. There was no correlation between rs5848 genotypes and serum GRN concentrations. Genotype frequencies of both polymorphisms did not differ between groups.Conclusion: Reduced circulating GRN levels might be associated with PD risk by pathogenic factors different from rs5848 and rs646776 polymorphisms.Keywords
This publication has 10 references indexed in Scilit:
- Extracellular progranulin protects cortical neurons from toxic insults by activating survival signalingNeurobiology of Aging, 2011
- No major progranulin genetic variability contribution to disease etiopathogenesis in an ALS Italian cohortNeurobiology of Aging, 2011
- rs5848 Variant of Progranulin Gene Is a Risk of Alzheimer’s Disease in the Taiwanese PopulationNeurodegenerative Diseases, 2011
- rs5848 polymorphism and serum progranulin levelJournal of the Neurological Sciences, 2011
- Genome-wide Screen Identifies rs646776 near Sortilin as a Regulator of Progranulin Levels in Human PlasmaThe American Journal of Human Genetics, 2010
- Rs5848 Variant Influences GRN mRNA Levels in Brain and Peripheral Mononuclear Cells in Patients with Alzheimer's DiseaseJournal of Alzheimer’s Disease, 2009
- Serum biomarker for progranulin‐associated frontotemporal lobar degenerationAnnals of Neurology, 2009
- Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family membersBrain, 2009
- Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degenerationNeurology, 2008
- Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survivalJournal of Cell Biology, 2008